{"id":1377,"date":"2009-12-03T13:45:08","date_gmt":"2009-12-03T18:45:08","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/sensitive-troponin-assay-who-needs-it-not-me\/"},"modified":"2011-07-19T17:44:18","modified_gmt":"2011-07-19T21:44:18","slug":"sensitive-troponin-assay-who-needs-it-not-me","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2009\/12\/03\/sensitive-troponin-assay-who-needs-it-not-me\/","title":{"rendered":"Sensitive Troponin Assay: Who Needs It? Not Me!"},"content":{"rendered":"<p>Sensitive assays for troponin (see <a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/nejm\/content\/full\/361\/9\/868\">here<\/a> and <a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/nejm\/content\/full\/361\/9\/858\">here<\/a>) improve early diagnosis of acute myocardial infarction and risk stratification.\u00a0 However, <a href=\"http:\/\/cardioexchange.org\/nejm\/content\/full\/361\/26\/2538\">according to a recent NEJM study<\/a>, sensitive assays detect low circulating levels of cardiac troponin in the great majority (98%) of patients who have stable coronary artery disease and preserved LV systolic function.<br \/>\n\u00a0<br \/>\nIn many emergency departments, serum troponin levels are part of the routine \u201cscreening labs.\u201d Not uncommonly, elevated levels are found in patients without ACS, which leads to unnecessary admissions, cardiac evaluations, and procedures. Indiscriminant use of sensitive assays for troponin will only exacerbate this problem.<br \/>\n\u00a0<br \/>\nDo I really need (or want) access to a more sensitive assay for troponin?\u00a0 I\u2019m not convinced. It may be more harmful than helpful to the patient and physician.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sensitive assays for troponin (see here and here) improve early diagnosis of acute myocardial infarction and risk stratification.\u00a0 However, according to a recent NEJM study, sensitive assays detect low circulating levels of cardiac troponin in the great majority (98%) of patients who have stable coronary artery disease and preserved LV systolic function. \u00a0 In many [&hellip;]<\/p>\n","protected":false},"author":214,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1377","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/214"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=1377"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1377\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=1377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=1377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=1377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}